GridAI Technologies Corp. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that GridAI Technologies Corp. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $0 | Mar 30, 2020 |
| FY2019 | Dec 31, 2018 | $0 | Mar 30, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($18.06M) | Apr 9, 2025 |
| FY2024 | Dec 31, 2023 | ($15.79M) | Apr 9, 2025 |
| FY2023 | Dec 31, 2022 | ($14.63M) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($58.54M) | Mar 20, 2023 |
| FY2021 | Dec 31, 2020 | ($32.67M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($15.18M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($13.53M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($11.10M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($14.59M) | Mar 16, 2018 |
| FY2016 | Dec 31, 2015 | ($5.93M) | Mar 31, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($15.62M) | Apr 9, 2025 |
| FY2024 | Dec 31, 2023 | ($15.77M) | Apr 9, 2025 |
| FY2023 | Dec 31, 2022 | ($12.68M) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($59.06M) | Mar 20, 2023 |
| FY2021 | Dec 31, 2020 | ($26.43M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($14.74M) | Mar 31, 2021 |
| FY2018 | Dec 31, 2018 | ($13.43M) | Apr 1, 2019 |
| FY2018 | Dec 31, 2017 | ($10.22M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($6.33M) | Mar 16, 2018 |
| FY2016 | Dec 31, 2015 | ($4.73M) | Mar 31, 2017 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $903.9K | Apr 9, 2025 |
| FY2024 | Dec 31, 2023 | $5.03M | Apr 9, 2025 |
| FY2023 | Dec 31, 2022 | $8.78M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $16.99M | Mar 20, 2023 |
| FY2020 | Dec 31, 2020 | $5.89M | Mar 31, 2021 |
| FY2020 | Dec 31, 2019 | $8.68M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $5.77M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $2.40M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $2.50M | Mar 16, 2018 |
| FY2016 | Dec 31, 2015 | $1.40M | Mar 31, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($9.22M) | Apr 9, 2025 |
| FY2024 | Dec 31, 2023 | ($12.38M) | Apr 9, 2025 |
| FY2023 | Dec 31, 2022 | ($22.34M) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($32.29M) | Mar 20, 2023 |
| FY2021 | Dec 31, 2020 | ($11.22M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($14.03M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($10.87M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($7.18M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($4.53M) | Mar 16, 2018 |
| FY2016 | Dec 31, 2015 | ($4.17M) | Mar 31, 2017 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2021 | $69.5K | Mar 20, 2023 |
| FY2021 | Dec 31, 2020 | $4.2K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $24.1K | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $55.5K | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $32.2K | Apr 1, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $85.41M | Apr 9, 2025 |
| FY2024 | Dec 31, 2023 | $6.88M | Apr 9, 2025 |
| FY2023 | Dec 31, 2022 | $5.44M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $11.79M | Mar 20, 2023 |
| FY2021 | Dec 31, 2020 | $12.92M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $8.90M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $7.47M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $5.48M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $6.75M | Mar 16, 2018 |
| FY2016 | Dec 31, 2015 | $6.69M | Mar 31, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $27.61M | Apr 9, 2025 |
| FY2024 | Dec 31, 2023 | $3.28M | Apr 9, 2025 |
| FY2023 | Dec 31, 2022 | $2.70M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $19.61M | Mar 20, 2023 |
| FY2021 | Dec 31, 2020 | $15.56M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $4.29M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $3.00M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $3.82M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $3.54M | Mar 16, 2018 |
| FY2016 | Dec 31, 2015 | $10.32M | Mar 31, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($3.88M) | Apr 9, 2025 |
| FY2024 | Dec 31, 2023 | $3.60M | Apr 9, 2025 |
| FY2024 | Dec 31, 2022 | $2.74M | Apr 9, 2025 |
| FY2023 | Dec 31, 2021 | ($7.82M) | Mar 29, 2024 |
| FY2021 | Sep 30, 2021 | $6.97M | Mar 31, 2022 |
| FY2022 | Dec 31, 2020 | ($2.64M) | Mar 20, 2023 |
| FY2021 | Dec 31, 2019 | $4.62M | Mar 31, 2022 |
| FY2020 | Dec 31, 2018 | $4.47M | Mar 31, 2021 |
| FY2019 | Dec 31, 2017 | $1.66M | Mar 30, 2020 |
| FY2018 | Dec 31, 2016 | $3.21M | Apr 1, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $1.68M | Apr 9, 2025 |
| FY2024 | Dec 31, 2023 | $1.68M | Apr 9, 2025 |
| FY2024 | Dec 31, 2022 | $1.68M | Apr 9, 2025 |
| FY2023 | Dec 31, 2021 | $1.91M | Mar 29, 2024 |
| FY2022 | Dec 31, 2020 | $2.05M | Mar 20, 2023 |
| FY2021 | Dec 31, 2019 | $1.89M | Mar 31, 2022 |
| FY2020 | Dec 31, 2018 | $1.92M | Mar 31, 2021 |
| FY2019 | Dec 31, 2017 | $2.02M | Mar 30, 2020 |
| FY2018 | Dec 31, 2016 | $1.77M | Apr 1, 2019 |
| FY2017 | Dec 31, 2015 | $1.83M | Mar 16, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($202.39M) | Apr 9, 2025 |
| FY2024 | Dec 31, 2023 | ($184.33M) | Apr 9, 2025 |
| FY2023 | Dec 31, 2022 | ($168.53M) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($153.90M) | Mar 20, 2023 |
| FY2021 | Dec 31, 2020 | ($95.37M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($62.69M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($47.52M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($33.98M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($22.89M) | Mar 16, 2018 |
| FY2016 | Dec 31, 2015 | ($8.30M) | Mar 31, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $163.5K | Apr 9, 2025 |
| FY2024 | Dec 31, 2023 | $3.71M | Apr 9, 2025 |
| FY2023 | Dec 31, 2022 | $1.36M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $8.25M | Mar 20, 2023 |
| FY2021 | Dec 31, 2020 | $6.06M | Mar 31, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | (5) | Apr 9, 2025 |
| FY2024 | Dec 31, 2023 | (47) | Apr 9, 2025 |
| FY2023 | Dec 31, 2022 | (416) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | (1,988) | Mar 20, 2023 |
| FY2021 | Dec 31, 2020 | (14) | Mar 31, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | (5) | Apr 9, 2025 |
| FY2024 | Dec 31, 2023 | (47) | Apr 9, 2025 |
| FY2023 | Dec 31, 2022 | (416) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | (1,988) | Mar 20, 2023 |
| FY2021 | Dec 31, 2020 | (14) | Mar 31, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 4.75M | Apr 9, 2025 |
| FY2024 | Dec 31, 2023 | 1.56M | Apr 9, 2025 |
| FY2023 | Dec 31, 2022 | 49,750 | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | 70,742 | Mar 20, 2023 |
| FY2021 | Dec 31, 2020 | 3.12M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | 26.80M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 17.70M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | 12.04M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | 9.63M | Mar 16, 2018 |
| FY2016 | Dec 31, 2015 | 4.30M | Mar 31, 2017 |